公开(公告)号：US20250093361A1

公开(公告)日：2025-03-20

申请号：US18897474

申请日：2024-09-26

Applicant: Ajinomoto Co., Inc.

Inventor： Takayuki TANAKA ,  Kenji NAGAO ,  Akira IMAIZUMI ,  Minoru YAMAKADO

IPC: G01N33/68 ,  G16H50/30

Abstract: A method of evaluating lifestyle-related disease indicator includes (i) an obtaining step of obtaining amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated and (ii) an evaluating step of evaluating a state of an indicator of lifestyle-related disease for the subject using the concentration values of the amino acids of Gly and Tyr included in the amino acid concentration data of the subject obtained at the obtaining step.

公开(公告)号：US20210172958A1

公开(公告)日：2021-06-10

申请号：US17178805

申请日：2021-02-18

Applicant: AJINOMOTO CO., INC.

Inventor： Takashi MIKAMI ,  Akira IMAIZUMI ,  Takayuki TANAKA ,  Yuki MIYAZAWA ,  Mina NAKAMURA ,  Kazuki NAKAGAWA ,  Takeshi FUJIEDA

IPC: G01N33/68 ,  G01N33/62 ,  G01N33/66 ,  G01N33/92

Abstract: An evaluating method includes an evaluating step of evaluating a state of ketosis in postpartum dairy cows for a dairy cow using at least one value of concentration values of Ala, Arg, Asn, Asp, BCAA, Cit, Cys, Glu, Gln, Gly, His, Ile, Leu, Lys, Met, 3MeHis, Orn, Phe, Pro, Ser, Tau, Thr, Trp, Tyr, and Val and concentration values of ALB, ALT, AST, BHBA, BUN, Ca, gGTP, Glc, NEFA, T-Bil, TCHO, TG, and TP in blood of the dairy cow before parturition.

公开(公告)号：US20190228844A1

公开(公告)日：2019-07-25

申请号：US16373427

申请日：2019-04-02

Applicant: AJINOMOTO CO., INC.

Inventor： Hidehiro NAKAMURA ,  Natsumi NISHIKATA ,  Akira IMAIZUMI ,  Kazutaka SHIMBO ,  Naoko ARASHIDA ,  Rumi NISHIMOTO

IPC: G16C20/70

Abstract: An evaluating method includes an evaluating step of evaluating a state of colorectal cancer for a subject to be evaluated using (i) a concentration value of at least one metabolite of bABA, N-Me-bABA, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, GABA, Homoarginine, Hypotaurine, Kinurenine, N6-Acetyl-L-Lys, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, SDMA, Acylcarnitine (13:1), and EPA in blood of the subject or (ii) a value of a formula calculated using the concentration value of the metabolite and the formula including an explanatory variable to be substituted with the concentration value of the metabolite.

公开(公告)号：US20170206335A1

公开(公告)日：2017-07-20

申请号：US15479786

申请日：2017-04-05

Applicant: AJINOMOTO CO., INC.

Inventor： Kenji NAGAO ,  Akira IMAIZUMI ,  Minoru YAMAKADO

IPC: G06F19/00 ,  G01N33/68

CPC classification number: G16H50/30 ,  G01N33/6806 ,  G01N2800/22 ,  G01N2800/2871 ,  G01N2800/326 ,  G01N2800/50

Abstract: An evaluating method includes an evaluating step of evaluating a future risk of lifestyle-related disease for a subject to be evaluated using a concentration value of an amino acid included in amino acid concentration data on the concentration value of the amino acid in blood collected from the subject.